Act Capital Management, LLC Natera, Inc. Transaction History

Act Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$28.13 - $44.54 $154,715 - $244,970	-5,500 Reduced 44.0%	7,000 $248,000
Q1 2022 May 11, 2022	SELL	$30.32 - $91.33 $603,368 - $1.82 Million	-19,900 Reduced 61.42%	12,500 $509,000
Q4 2021 Feb 03, 2022	BUY	$86.26 - $119.0 $560,690 - $773,500	6,500 Added 25.1%	32,400 $3.03 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $2.23 Million - $3.1 Million	25,900 New	25,900 $2.94 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Act Capital Management, LLC with notifications on news.